Bioextrax AB (85X0) Financial Statements
Bioextrax AB Financial Overview
Bioextrax AB's market cap is currently $10.49M. The company's EPS TTM is $-0.34; its P/E ratio is -5.39; Bioextrax AB is scheduled to report earnings on November 20, 2026, and the estimated EPS forecast is $-0.01. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 757.00K | $ 515.00K | $ 2.06M | $ 395.00K | $ 275.76K |
| Gross Profit | $ -16.43M | $ -915.00K | $ 718.00K | $ -18.64M | $ -11.29M |
| Operating Income | $ -18.37M | $ -17.54M | $ -21.60M | $ -20.62M | $ -11.29M |
| EBITDA | $ -17.24M | $ -16.18M | $ -20.65M | $ -18.19M | $ -10.18M |
| Net Income | $ -17.70M | $ -17.34M | $ -21.51M | $ -18.67M | $ -10.53M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 3.93M | $ 17.27M | $ 13.40M | $ 27.53M | $ 8.98M |
| Total Assets | $ 24.73M | $ 29.00M | $ 22.52M | $ 37.92M | $ 12.64M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -3.93M | $ -17.27M | $ -13.40M | $ -27.53M | $ -8.98M |
| Total Liabilities | $ 3.51M | $ 2.94M | $ 1.98M | $ 6.15M | $ 5.14M |
| Stockholders' Equity | $ 21.21M | $ 26.06M | $ 20.54M | $ 31.77M | $ 7.50M |
| Cash Flow | |||||
| Free Cash Flow | $ -26.20M | $ -18.99M | $ -24.41M | $ -24.38M | $ -9.45M |
| Operating Cash Flow | $ -26.05M | $ -18.78M | $ -23.31M | $ -17.60M | $ -8.48M |
| Investing Cash Flow | $ -152.00K | $ -215.00K | $ -1.10M | $ -6.78M | $ -975.13K |
| Financing Cash Flow | $ 12.86M | $ 22.86M | $ 10.28M | $ 42.94M | $ 16.38M |
Currency in SEK